Lacosamide Adroiq
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lacosamide Adroiq, covering 2026-01-21 to 2026-08-07. Get the full timeline:
Most recent: EMA Authorised: Lacosamide Adroiq (lacosamide) — Extrovis EU Ltd